Cardiovascular Revascularization Medicine
Volume 9, Issue 2 , Pages 78-87, April 2008

Platelet function in intravascular device implant-induced intimal injury☆

  • Belay Tesfamariam

      Affiliations

    • Corresponding Author InformationDivision of Cardiovascular and Renal, CDER, FDA, Bldg 22, Rm 4176, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA. Tel.: +1 301 796 1154; fax: +1 301 796 9841.

Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA

Received 25 October 2007; received in revised form 3 December 2007; accepted 4 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclaimer: The opinions expressed in this article are those of the author and do not represent FDA policy.

PII: S1553-8389(07)00341-7

doi:10.1016/j.carrev.2007.12.001

Cardiovascular Revascularization Medicine
Volume 9, Issue 2 , Pages 78-87, April 2008

Article Tools

* Image Usage & Resolution